Skip to content

TLG-001J Confirmatory Clinical Trial

Multicenter, Randomized, Double-blind, Pseudo-placebo-controlled, Parallel-group Confirmatory Clinical Trial to Evaluate the Efficacy and Safety of TLG-001J in Myopic Schoolchildren

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2032220217
Enrollment
160
Registered
2022-07-16
Start date
2022-07-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

The subjects will be assigned randomly to the trial device or control device at a 1:1 ratio and wear the assigned device every day for 12 months. This will be followed by 12-month follow-up period wit

Sponsors

Tsubota Kazuo
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Male and female Japanese schoolchildren who are 6 to 12 years old at the time of informed consent - Anisometropia is within 1.50 D - Astigmatism, cycloplegic objective refraction (C), is within +/- 1.50 D for each eye

Exclusion criteria

Exclusion criteria: - A history of refractive and/or other form of ophthalmic surgery - Impaired binocular visual function - Amblyopia or manifest strabismus - Individuals who are likely to require contact lenses (e.g., monofocal, bifocal, orthokeratology) or multifocal eyeglasses during the trial

Design outcomes

Primary

MeasureTime frame
Change from baseline in cycloplegic objective refraction: SE at Month 12 of investigational device use

Secondary

MeasureTime frame
Changes from baseline in axial length at Months 1, 3, 6, 9, and 12 of device use, and others

Contacts

Public ContactShinichiro Kondo

Tsubota Laboratory, Inc.

kondo@tsubota-lab.com+81-3-6384-2866

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026